Neurocrine Biosciences, Inc. (NBIX)
138.94
-0.55
(-0.39%)
USD |
NASDAQ |
Sep 24, 16:00
140.34
+1.40
(+1.01%)
After-Hours: 05:14
Neurocrine Biosciences Gross Profit (Annual) : 2.808B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.808B |
| December 31, 2024 | 2.298B |
| December 31, 2023 | 1.830B |
| December 31, 2022 | 1.450B |
| December 31, 2021 | 1.108B |
| December 31, 2020 | 1.027B |
| December 31, 2019 | 773.21M |
| December 31, 2018 | 446.35M |
| December 31, 2017 | 159.17M |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | -0.827M |
| December 31, 2013 | 2.248M |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 76.72M |
| Date | Value |
|---|---|
| December 31, 2010 | 32.06M |
| December 31, 2009 | -0.226M |
| December 31, 2008 | -3.635M |
| December 31, 2007 | -8.18M |
| December 31, 2006 | 28.67M |
| December 31, 2005 | 113.80M |
| December 31, 2004 | 78.10M |
| December 31, 2003 | 135.39M |
| December 31, 2002 | 14.95M |
| December 31, 2001 | 38.59M |
| December 31, 2000 | 12.39M |
| December 31, 1999 | -12.38M |
| December 31, 1998 | -5.766M |
| December 31, 1997 | 6.256M |
| December 31, 1996 | 6.646M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Amarin Corp. Plc | 118.12M |
| Liquidia Corp. | 144.25M |
| BioCryst Pharmaceuticals, Inc. | 854.37M |
| Halozyme Therapeutics, Inc. | 1.091B |
| Iovance Biotherapeutics, Inc. | 54.38M |